277 related articles for article (PubMed ID: 35980281)
1. COVID-19 and vaccination: myths vs science.
Chavda VP; Chen Y; Dave J; Chen ZS; Chauhan SC; Yallapu MM; Uversky VN; Bezbaruah R; Patel S; Apostolopoulos V
Expert Rev Vaccines; 2022 Nov; 21(11):1603-1620. PubMed ID: 35980281
[TBL] [Abstract][Full Text] [Related]
2. Clinical development and approval of COVID-19 vaccines.
Kalinke U; Barouch DH; Rizzi R; Lagkadinou E; Türeci Ö; Pather S; Neels P
Expert Rev Vaccines; 2022 May; 21(5):609-619. PubMed ID: 35157542
[TBL] [Abstract][Full Text] [Related]
3. A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists.
Yaseen MO; Saif A; Khan TM; Yaseen M; Saif A; Bukhsh A; Shahid MN; Alsenani F; Tahir H; Ming LC; Amin MU; Suleiman AK; Al-Worafi YM; Baig MR; Saeed Imran M; Jaber AA
Hum Vaccin Immunother; 2022 Dec; 18(1):2031455. PubMed ID: 35192781
[TBL] [Abstract][Full Text] [Related]
4. mRNA Vaccines in the COVID-19 Pandemic and Beyond.
Hogan MJ; Pardi N
Annu Rev Med; 2022 Jan; 73():17-39. PubMed ID: 34669432
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy.
Ameratunga R
Expert Rev Vaccines; 2022 Sep; 21(9):1177-1184. PubMed ID: 35695410
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
[TBL] [Abstract][Full Text] [Related]
7. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Vaccines: Where Are We Now?
Flanagan KL; MacIntyre CR; McIntyre PB; Nelson MR
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3535-3543. PubMed ID: 34400116
[TBL] [Abstract][Full Text] [Related]
9. The race for a COVID-19 vaccine: where are we up to?
Hossain MK; Hassanzadeganroudsari M; Feehan J; Apostolopoulos V
Expert Rev Vaccines; 2022 Mar; 21(3):355-376. PubMed ID: 34937492
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide.
Hussain H; Ganesh A; Milane L; Amiji M
Expert Opin Drug Deliv; 2023 Apr; 20(4):489-506. PubMed ID: 36890642
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic.
Shao Y; Wu Y; Feng Y; Xu W; Xiong F; Zhang X
Front Med; 2022 Apr; 16(2):185-195. PubMed ID: 35226300
[TBL] [Abstract][Full Text] [Related]
12. [Vaccination contre le SARS-CoV-2, le Graal ?].
Binh Luong Nguyen L; Lachâtre M; Launay O
Rev Prat; 2022 May; 72(5):517-522. PubMed ID: 35899638
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2: vaccines in the pandemic era.
Li DD; Li QH
Mil Med Res; 2021 Jan; 8(1):1. PubMed ID: 33402220
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns.
Zellweger RM; Wartel TA; Marks F; Song M; Kim JH
Expert Rev Vaccines; 2020 Aug; 19(8):691-698. PubMed ID: 32838605
[TBL] [Abstract][Full Text] [Related]
15. The role of vaccines in the COVID-19 pandemic: what have we learned?
Krammer F
Semin Immunopathol; 2024 Jan; 45(4-6):451-468. PubMed ID: 37436465
[TBL] [Abstract][Full Text] [Related]
16. Vaccination Hesitancy and Conspiracy Beliefs in the UK During the SARS-COV-2 (COVID-19) Pandemic.
Bacon AM; Taylor S
Int J Behav Med; 2022 Aug; 29(4):448-455. PubMed ID: 34599463
[TBL] [Abstract][Full Text] [Related]
17. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
18. Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.
Chen JM; Sun YX; Chen JW
J Med Virol; 2020 Nov; 92(11):2453-2457. PubMed ID: 32525587
[TBL] [Abstract][Full Text] [Related]
19. [SARS-CoV-2 vaccines].
Benfield TL; Helweg-Larsen J
Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
[TBL] [Abstract][Full Text] [Related]
20. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.
Piñana JL; Vázquez L; Martino R; de la Cámara R; Sureda A; Rodríguez-Veiga R; Garrido A; Sierra J; Ribera JM; Torrent A; Mateos MV; de la Rubia J; Tormo M; Díez-Campelo M; García-Gutiérrez V; Álvarez-Larrán A; Sancho JM; MartínGarcía-Sancho A; Yañez L; Pérez Simón JA; Barba P; Abrisqueta P; Álvarez-Twose I; Bonanad S; Lecumberri R; Ruiz-Camps I; Navarro D; Hernández-Rivas JÁ; Cedillo Á; García-Sanz R; Bosch F
Leuk Lymphoma; 2022 Mar; 63(3):538-550. PubMed ID: 34668835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
